Technical Analysis for ANGN - Angion Biomedica Corp.

Grade Last Price % Change Price Change
F 13.82 -3.42% -0.49
ANGN closed down 3.42 percent on Wednesday, May 5, 2021, on 50 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical ANGN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish -3.42%
Crossed Above 20 DMA Bullish -5.60%
NR7 Range Contraction -2.19%
Down 3 Days in a Row Weakness -2.19%
20 DMA Resistance Bearish -2.33%
Outside Day Range Expansion -2.33%
Wide Bands Range Expansion -2.33%
NR7 Range Contraction -3.89%
NR7-2 Range Contraction -3.89%
Older End-of-Day Signals for ANGN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 8 hours ago
Down 3% about 8 hours ago
Down 2 % about 8 hours ago
Fell Below Previous Day's Low about 8 hours ago
10 DMA Support about 9 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3777, a hepatocyte growth factor mimetic for acute kidney injury, acute lung injury, acute respiratory distress syndrome, central nervous system injuries, and heart injuries. It also develops products, such as ANG-3070 tyrosine kinase inhibitor and rho kinase 2 inhibitor for fibrotic diseases; and CYP11B2, an aldosterone synthase inhibitor for aldosterone-related fibrotic diseases. The company was founded in 1998 and is headquartered in Uniondale, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Tyrosine Kinase Protein Kinase Inhibitor Fibrotic Diseases Acute Kidney Injury Acute Respiratory Distress Syndrome

Is ANGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.3
52 Week Low 12.5589
Average Volume 146,714
200-Day Moving Average 0.00
50-Day Moving Average 16.86
20-Day Moving Average 14.35
10-Day Moving Average 14.22
Average True Range 1.09
ADX 20.37
+DI 16.50
-DI 22.85
Chandelier Exit (Long, 3 ATRs ) 14.31
Chandelier Exit (Short, 3 ATRs ) 15.82
Upper Bollinger Band 15.63
Lower Bollinger Band 13.07
Percent B (%b) 0.29
BandWidth 17.82
MACD Line -0.80
MACD Signal Line -0.96
MACD Histogram 0.1679
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.98
Resistance 3 (R3) 15.08 14.79 14.78
Resistance 2 (R2) 14.79 14.50 14.74 14.72
Resistance 1 (R1) 14.31 14.32 14.17 14.21 14.65
Pivot Point 14.02 14.02 13.95 13.97 14.02
Support 1 (S1) 13.54 13.73 13.40 13.44 12.99
Support 2 (S2) 13.25 13.55 13.20 12.92
Support 3 (S3) 12.77 13.25 12.86
Support 4 (S4) 12.67